Skip to content
Screener
Gaxos.ai logo

Gaxos.ai

GXAI

Gaxos.ai Inc. is a technology company that develops and manages a portfolio of artificial intelligence solutions across defense, health, entertainment, and productivity sectors.

Market cap
$5.75M-44.0%

Earnings

Next report

Date not yet announced

Competitors

Profile

Gaxos.ai Inc. is a technology company that develops and manages a portfolio of artificial intelligence solutions across defense, health, entertainment, and productivity sectors. The company focuses on making advanced AI practical for everyday use through generative AI tools, personalized health optimization, and AI-integrated gaming experiences.

Competitive position

Gaxos.ai is an early-stage diversified AI developer positioning itself as a cross-industry integrator of generative AI and health-tech solutions.

GeographiesUnited States
Customer segmentsEnterprise, Retail Consumers, Developers
Business modelB2B, B2C, SaaS, Freemium, E-commerce
SuppliersCloud infrastructure providers, AI model developers (Google, Stability AI, PixVerse), Game engines (Unity, Godot), Pharmaceutical and supplement manufacturers
CustomersIndependent game studios, Digital content creators, Individual health and wellness consumers, Mobile and PC gamers
Listed2023
Employees3.0
CEOVadim Mats
Websitegaxos.ai
FilingsSEC EDGAR

FAQ

What is Gaxos.ai's market cap?
Gaxos.ai (GXAI) has a market capitalization of $5.7M and trades on NASDAQ.
Who are Gaxos.ai's competitors?
Gaxos.ai's key competitors include Microsoft, Blaize Holdings, Inc. Common Stock, GD Culture Group Limited Common Stock, and others. These companies compete in similar markets and product categories.
Who does Gaxos.ai partner with?
Gaxos.ai's notable partners include Nekwellness, LLC, Google, Stability AI, and others.
What subsidiaries does Gaxos.ai have?
Gaxos.ai's subsidiaries include RNK Health LLC.
Where is Gaxos.ai headquartered?
Gaxos.ai is headquartered in United States of America and employs approximately 3 people. It has been publicly traded since 2023.